Table 4.
Comparison of the Frequency Percent of Some Hematological and Biochemical Abnormalities of the Included COVID-19 Patients Measured at Admission, in Terms of COVID-19 Severity
| Variables (No.,%) | COVID-19 Severity | p-value | ||||
|---|---|---|---|---|---|---|
| Mild to Moderate (n= 36) | Severe/Critical (n= 30) | |||||
| Hb | > 11 g/dL | 36 | 100% | 30 | 100% | —– |
| ˂11 g/dL | 0 | 0% | 0 | 0% | ||
| WBC | > 4 x103 mm−3 | 29 | 80.6% | 19 | 63.3% | 0.118 |
| ˂4 x103 mm−3 | 7 | 19.4% | 11 | 36.7% | ||
| Lymphocyte count | > 1 x103 mm−3 | 18 | 50% | 5 | 16.7% | 0.005 |
| ˂1 x103 mm−3 | 18 | 50% | 25 | 83.3% | ||
| CRP | < 100 mg/dL | 36 | 100% | 6 | 20% | < 0.001 |
| ≥ 100 mg/dL | 0 | 0% | 24 | 80% | ||
| ESR | <30 mm/h | 10 | 27.8% | 3 | 10% | 0.071 |
| ˃30 mm/h | 26 | 72.2% | 27 | 90% | ||
| Serum ferritin | < 350 ng/mL | 30 | 83.3% | 4 | 13.3% | < 0.001 |
| ˃350 ng/mL | 6 | 16.7% | 26 | 86.7% | ||
| Serum creatinine | < 1.2 mg/dL | 36 | 100% | 30 | 100% | —– |
| ˃ 1.2 mg/dL | 0 | 0% | 0 | 0% | ||
| Total protein | > 6 g/dL | 36 | 100% | 30 | 100% | —– |
| ˂6 g/dL | 0 | 0% | 0 | 0% | ||
| Albumin | > 3.4 g/dL | 1 | 2.8% | 1 | 3.3% | 0.896 |
| ˂3.4 g/dL | 35 | 97.2% | 29 | 96.7% | ||
| ALT | < 40 IU/L | 32 | 88.9% | 11 | 36.7% | < 0.001 |
| ˃40 IU/L | 4 | 11.1% | 19 | 63.3% | ||
| AST (IU/L) | < 40 IU/L | 34 | 94.4% | 6 | 20% | < 0.001 |
| ˃40 IU/L | 2 | 5.6% | 24 | 80% | ||
Notes: p-value < 0.05 is considered significant. p-value > 0.05 is considered non-significant.
Abbreviations: COVID-19, coronavirus disease-2019; Hb, hemoglobin; WBC, white blood cell count; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; ALT, alanine aminotransferase; AST, aspartate aminotransferase.